Abstract:Importance: Metabolic deregulation plays an important role in gastric cancer (GC) development. To date, no studies have comprehensively explored the metabolomic profiles along the cascade of gastric lesions toward GC. Objective: To draw a metabolic landscape and define metabolomic signatures associated with the progression of gastric lesions and risk of early GC. Design, setting, and participants: A 2-stage, population-based cohort study was initiated in 2017 in Linqu County, Shandong Province, China, a high-risk area for GC. Prospective follow-up was conducted during the validation stage (June 20, 2017, to May 27, 2020). A total of 400 individuals were included based on the National Upper Gastrointestinal Cancer Early Detection Program in China. The discovery stage involved 200 individuals with different gastric lesions or GC (high-grade intraepithelial neoplasia or invasive GC). The validation stage prospectively enrolled 152 individuals with gastric lesions who were followed up for 118 to 1063 days and 48 individuals with GC. Exposures: Metabolomic profiles and metabolite signatures were examined based on untargeted plasma metabolomics assay. Main outcomes and measures: The risk of GC overall and early GC (high-grade intraepithelial neoplasia), and progression of gastric lesions. Results: Of the 400 participants, 124 of 200 (62.0%) in the discovery set were men; mean (SD) age was 56.8 (7.5) years. In the validation set, 136 of 200 (68.0%) were men; mean (SD) age was 57.5 (8.1) years. Distinct metabolomic profiles were noted for gastric lesions and GC. Six metabolites, including α-linolenic acid, linoleic acid, palmitic acid, arachidonic acid, sn-1 lysophosphatidylcholine (LysoPC)(18:3), and sn-2 LysoPC(20:3) were significantly inversely associated with risk of GC overall and early GC (high-grade intraepithelial neoplasia). Among these metabolites, the first 3 were significantly inversely associated with gastric lesion progression, especially for the progression of intestinal metaplasia (α-linolenic acid: OR, 0.42; 95% CI, 0.18-0.98; linoleic acid: OR, 0.43; 95% CI, 0.19-1.00; and palmitic acid: OR, 0.32; 95% CI, 0.13-0.78). Compared with models including only age, sex, Helicobacter pylori infection, and gastric histopathologic findings, integrating these metabolites significantly improved the performance for predicting the progression of gastric lesions (area under the curve [AUC], 0.86; 95% CI, 0.70-1.00 vs AUC, 0.69; 95% CI, 0.50-0.88; P = .02) and risk of early GC (AUC, 0.83; 95% CI, 0.58-1.00 vs AUC, 0.61; 95% CI, 0.31-0.91; P = .03). Conclusions and relevance: This study defined metabolite signatures that might serve as meaningful biomarkers for assessing high-risk populations and early diagnosis of GC, possibly advancing targeted GC prevention and control.

Precancerous Lesions In Two Counties Of China With Contrasting Gastric Cancer Risk

Evolution of Precancerous Lesions in a Rural Chinese Population at High Risk of Gastric Cancer

A Study of Precancerous Gastric Lesions in a High Risk Population

Age and sites-specific prevalence rates of precancerous gastric lesions at a high-risk population of stomach cancer

Etiology and prevention of gastric cancer: a population study in a high risk area of China

Helicobacter Pylori Infection, Garlic Intake And Precancerous Lesions In A Chinese Population At Low Risk Of Gastric Cancer

Genetic Polymorphism of Psca and Risk of Advanced Precancerous Gastric Lesions in A Chinese Population

Serum Antibodies to Helicobacter Pylori and the Caga Antigen Do Not Explain Differences in the Prevalence of Precancerous Gastric Lesions in Two Chinese Populations with Contrasting Gastric Cancer Rates

An epidemiological evidence of multistage process of stomach cancer

Epidemiology of precancerous gastric lesions.

Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer

Esophageal Cancer in High-Risk Areas of China: Research Progress and Challenges

Gastric Dysplasia and Gastric Cancer: Helicobacter pylori, Serum Vitamin C, and Other Risk Factors

Genetic Polymorphisms Of Cyp2e1, Gstt1, Gstp1, Gstm1, Aldh2, And Odc And The Risk Of Advanced Precancerous Gastric Lesions In A Chinese Population

Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions

Gastric Mucosal Status and Risk of Gastric Cancer in High‐Risk Individuals: A Population‐Based, Multicenter Prospective Study in China

Risk Factors of Early Proximal Gastric Carcinoma in Chinese Diagnosed with the WHO Criteria.

A Multicenter Study Assessing the Prevalence of Germline Genetic Alterations in Chinese Gastric-Cancer Patients

Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.

Microbiota alteration at different stages in gastric lesion progression: a population-based study in Linqu, China

Histopathological Comparison of the Lesions at Esophagus, Gastric Cardia and Antrum on the Subjects from Linzhou, Henan and the Linzhou Migrated Subjects from Changzhi, Shanxi